Related Experiment Video
Updated: Jul 15, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Safety outcomes when switching between biosimilars and reference biologics: A systematic review and meta-analysis
Thomas M Herndon1, Cristina Ausin1, Nina N Brahme1
1Office of Therapeutic Biologics and Biosimilars, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America.
Switching patients to biosimilars from reference biologics is safe. A systematic review found no significant differences in safety or immunogenicity when patients switched treatments, supporting biosimilar adoption.
Area of Science:
- Pharmacology
- Immunology
- Clinical Medicine
Background:
- Biosimilars offer alternatives for treating serious disorders.
- Concerns exist regarding switching patients from reference biologics to biosimilars.
Conclusions:
- Switching patients between reference biologics and biosimilars does not alter safety profiles or immunogenicity.
- Findings support the safe use of biosimilars in clinical practice, even with treatment switches.
More Related Videos
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioequivalence: Overview
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Biopharmaceutics and Pharmacokinetics: Overview
Comparing the Survival Analysis of Two or More Groups